Rational approaches for transgene expression: Targeted integration and episomal maintenance

Animal Cell Biotechnology: In Biologics Production

Volumn , Issue , 2014, Pages 173-215

  Kruse, Natascha ^a   Spencer, Shawal ^a   Wirth, Dagmar ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC ENGINEERING;

TRANSGENE EXPRESSION;

BIOTECHNOLOGY;

EID: 84979153673     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1515/9783110278965.173     Document Type: Chapter

References (258)

1. Blesch A. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer. Methods 2004;33:164-72.
2. Delenda C. Lentiviral vectors: optimization of packaging, transduction and gene expression. J Gene Med 2004;6(1):S125-38.
3. Matrai J, Chuah MK, VandenDriessche T. Recent advances in lentiviral vector development and applications. Mol Ther 2010;18:477-90.
4. Ivics Z, Izsvak Z. Nonviral gene delivery with the sleeping beauty transposon system. Hum Gene Ther 2011;22:1043-51.
5. Batenchuk C, St-Pierre S, Tepliakova L, et al. Chromosomal position effects are linked to sir2-mediated variation in transcriptional burst size. Biophys J 2011;100:L56-8.
6. Daboussi F, Zaslavskiy M, Poirot L, et al. Chromosomal context and epigenetic mechanisms control the efficacy of genome editing by rare-cutting designer endonucleases. Nucleic Acids Res 2012;40:6367-79.
7. Moreno R, Martinez I, Petriz J, et al. Boundary sequences stabilize transgene expression from subtle position effects in retroviral vectors. Blood Cells Mol Dis 2009;43:214-20.
8. Carlson CM, Dupuy AJ, Fritz S, et al. Transposon mutagenesis of the mouse germline. Genetics 2003;165:243-56.
9. Yant SR, Wu X, Huang Y et al. High-resolution genome-wide mapping of transposon integration in mammals. Mol Cell Biol 2005;25:2085-94.
10. Baum C, Kustikova O, Modlich U, et al. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther 2006;17:253-63.
11. Wu X, Li Y Crise B, et al. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003;300:1749-51.
12. Mitchell RS, Beitzel BF, Schroder AR, et al. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS biology 2004;2:E234.
13. Bode J, Schlake T, Rios-Ramirez M, et al. Scaffold/matrix-attached regions: structural properties creating transcriptionally active loci. Int Rev Cytol 1995;162(A):389-454.
14. Grandjean M, Girod PA, Calabrese D, et al. High-level transgene expression by homologous recombination-mediated gene transfer. Nucleic Acids Res 2011;39:e104.
15. Schubeler D, Mielke C, Maass K, et al. Scaffold/matrix-attached regions act upon transcription in a context-dependent manner. Biochemistry 1996;35:11160-9.
16. Laemmli UK, Kas E, Poljak L, et al. Scaffold-associated regions: cis-acting determinants of chromatin structural loops and functional domains. Curr Opin Genet Dev 1992;2:275-85.
17. Mielke C, Maass K, Tummler M, et al. Anatomy of highly expressing chromosomal sites targeted by retroviral vectors. Biochemistry 1996;35:2239-52.
18. Khan E, Mack JP, Katz RA, et al. Retroviral integrase domains: DNA binding and the recognition of LTR sequences. Nucleic Acids Res 1991;19:851-60.
19. Eckdahl TT, Anderson JN. Conserved DNA structures in origins of replication. Nucleic Acids Res 1990;18:1609-12.
20. Evans K, Ott S, Hansen A, et al. A comparative study of S/MAR prediction tools. BMC Bioinformatics 2007;8:71.
21. Liebich I, Bode J, Frisch M, et al. S/MARt DB: a database on scaffold/matrix attached regions. Nucleic Acids Res 2002;30:372-4.
22. Girod PA, Nguyen DQ, Calabrese D, et al. Genome-wide prediction of matrix attachment regions that increase gene expression in mammalian cells. Nat Meth 2007;4:747-53.
23. Klehr D, Maass K, Bode J. Scaffold-attached regions from the human interferon beta domain can be used to enhance the stable expression of genes under the control of various promoters. Biochemistry 1991;30:1264-70.
24. Harraghy N, Gaussin A, Mermod N. Sustained transgene expression using MAR elements. Curr Gene Ther 2008;8:353-66.
25. Buceta M, Galbete JL, Kostic C, et al. Use of human MAR elements to improve retroviral vector production. Gene Ther 2011;18:7-13.
26. Bell AC, Felsenfeld G. Stopped at the border: boundaries and insulators. Curr Opin Genet Dev 1999;9:191-8.
27. Dietz A, Kay V, Schlake T, et al. A plant scaffold attached region detected close to a T-DNA integration site is active in mammalian cells. Nucleic Acids Res 1994;22:2744-51.
28. Harraghy N, Buceta M, Regamey A, et al. Using matrix attachment regions to improve recombinant protein production. Methods Mol Biol 2012;801:93-110.
29. Grabundzija I, Wang J, Sebe A, et al. Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells. Nucleic Acids Res 2013;41:1829-47.
30. Girod PA, Zahn-Zabal M, Mermod N. Use of the chicken lysozyme 5’ matrix attachment region to generate high producer CHO cell lines. Biotechnol Bioeng 2005;91:1-11.
31. Murrell A, Heeson S, Reik W. Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nat Genet 2004;36:889-93.
32. Reik W, Murrell A, Lewis A, et al. Chromosome loops, insulators, and histone methylation: new insights into regulation of imprinting in clusters. Cold Spring Harb Symp Quant Biol 2004;69:29-37.
33. West AG, Gaszner M, Felsenfeld G. Insulators: many functions, many mechanisms. Genes Dev 2002;16:271-88.
34. Matzat LH, Dale RK, Lei EP. Messenger RNA is a functional component of a chromatin insulator complex. EMBO Rep 2013;14(10):916-22.
35. Lewis A, Murrell A. Genomic imprinting: CTCF protects the boundaries. Curr Biol 2004;14:R284-6.
36. Herold M, Bartkuhn M, Renkawitz R. CTCF: insights into insulator function during development. Development;139:1045-57.
37. Valadez-Graham V, Razin SV, Recillas-Targa F. CTCF-dependent enhancer blockers at the upstream region of the chicken alpha-globin gene domain. Nucleic Acids Res 2004;32:1354-62.
38. Rincon-Arano H, Furlan-Magaril M, Recillas-Targa F. Protection against telomeric position effects by the chicken cHS4 beta-globin insulator. Proc Natl Acad Sci USA 2007;104:14044-9.
39. Roman AC, Gonzalez-Rico FJ, Molto E, et al. Dioxin receptor and SLUG transcription factors regulate the insulator activity of B1 SINE retrotransposons via an RNA polymerase switch. Genome Res 2011;21:422-32.
40. Hanawa H, Yamamoto M, Zhao H, et al. Optimized lentiviral vector design improves titer and transgene expression of vectors containing the chicken beta-globin locus HS4 insulator element. Mol Ther 2009;17:667-74.
41. Uchida N, Hanawa H, Yamamoto M, et al. The chicken hypersensitivity site 4 core insulator blocks promoter interference in lentiviral vectors. Hum Gene Ther Meth 2013;24:117-24.
42. Evans-Galea MV, Wielgosz MM, Hanawa H, et al. Suppression of clonal dominance in cultured human lymphoid cells by addition of the cHS4 insulator to a lentiviral vector. Mol Ther 2007;15:801-9.
43. Aker M, Tubb J, Groth AC, et al. Extended core sequences from the cHS4 insulator are necessary for protecting retroviral vectors from silencing position effects. Hum Gene Ther 2007;18:333-43.
44. Recillas-Targa F, Valadez-Graham V, Farrell CM. Prospects and implications of using chromatin insulators in gene therapy and transgenesis. Bioessays 2004;26:796-807.
45. Emery DW. The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors. Hum Gene Ther 2011;22:761-74.
46. Nielsen TT, Jakobsson J, Rosenqvist N, et al. Incorporating double copies of a chromatin insulator into lentiviral vectors results in less viral integrants. BMC Biotechnology 2009;9:13.
47. Dharshanan S, Chong H, Cheah SH, et al. Stable expression of H1C2 monoclonal antibody in NS0 and CHO cells using pFUSE and UCOE expression system. Cytotechnology 2013 (Epub ahead of print).
48. Zhang F, Frost AR, Blundell MP, et al. A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors. Mol Ther 2010;18:1640-9.
49. Pfaff N, Lachmann N, Ackermann M, et al. A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny. Stem Cells 2013;31:488-99.
50. Knight S, Zhang F, Mueller-Kuller U, et al. Safer, silencing-resistant lentiviral vectors: optimization of the ubiquitous chromatin-opening element through elimination of aberrant splicing. J Virol 2012;86:9088-95.
51. Kim S, Kim YW, Shim SH, et al. Chromatin structure of the LCR in the human beta-globin locus transcribing the adult delta- and beta-globin genes. Int J Biochem Cell Biol 2012;44:505-13.
52. Raich N, Enver T, Nakamoto B, et al. Autonomous developmental control of human embryonic globin gene switching in transgenic mice. Science 1990;250:1147-9.
53. Kim A, Dean A. Chromatin loop formation in the beta-globin locus and its role in globin gene transcription. Mol Cells 2012;34:1-5.
54. Indraccolo S, Minuzzo S, Roccaforte F, et al. Effects of CD2 locus control region sequences on gene expression by retroviral and lentiviral vectors. Blood 2001;98:3607-17.
55. Koh BH, Hwang SS, Kim JY, et al. Th2 LCR is essential for regulation of Th2 cytokine genes and for pathogenesis of allergic asthma. Proc Natl Acad Sci USA 2010;107:10614-9.
56. Smale ST. A Th2 cytokine LCR. Adding a new piece to the regulatory puzzle. Immunity 2003;19:1-2.
57. Palstra RJ, de Laat W, Grosveld F. Beta-globin regulation and long-range interactions. Adv Genet 2008;61:107-42.
58. Pawliuk R, Bachelot T, Raftopoulos H, et al. Retroviral vectors aimed at the gene therapy of human beta-globin gene disorders. Ann N Y Acad Sci 1998;850:151-62.
59. Ellis J, Pannell D. The beta-globin locus control region versus gene therapy vectors: a struggle for expression. Clin Genet 2001;59:17-24.
60. Morianos I, Siapati EK, Pongas G, et al. Comparative analysis of FV vectors with human alpha-or beta-globin gene regulatory elements for the correction of beta-thalassemia. Gene Ther 2012;19:303-11.
61. Kowolik CM, Hu J, Yee JK. Locus control region of the human CD2 gene in a lentivirus vector confers position-independent transgene expression. J Virol 2001;75:46 41-8.
62. Su Y, Liebhaber SA, Cooke NE. The human growth hormone gene cluster locus control region supports position-independent pituitary- and placenta-specific expression in the transgenic mouse. J Biol Chem 2000;275:7902-9.
63. Mei Q, Kothary R, Wall L. The tkNeo gene, but not the pgkPuro gene, can influence the ability of the beta-globin LCR to enhance and confer position-independent expression onto the beta-globin gene. Exp Cell Res 2000;260:304-12.
64. Montiel-Equihua CA, Zhang L, Knight S, et al. The beta-globin locus control region in combination with the EF1alpha short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activity. Mol Ther 2012;20:1400-9.
65. Arumugam PI, Higashimoto T, Urbinati F, et al. Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control region. Mol Ther 2009;17:1929-37.
66. Antoniou MN, Skipper KA, Anakok O. Optimizing retroviral gene expression for effective therapies. Hum Gene Ther 2013;24:363-74.
67. Hirano N, Muroi T, Takahashi H, et al. Site-specific recombinases as tools for heterologous gene integration. Appl Microbiol Biotechnol 2011;92:227-39.
68. Buchholz F, Ringrose L, Angrand PO, et al. Different thermostabilities of FLP and Cre recombinases: implications for applied site-specific recombination. Nucleic Acids Res 1996;24:4256-62.
69. Wirth D, Gama-Norton L, Riemer P, et al. Road to precision: recombinase-based targeting technologies for genome engineering. Curr Opin Biotechnol 2007;18:411-9.
70. Turan S, Zehe C, Kuehle J, et al. Recombinase-mediated cassette exchange (RMCE) - a rapidly-expanding toolbox for targeted genomic modifications. Gene 2013;515:1-27.
71. Spitzer J, Landthaler M, Tuschl T. Rapid Creation of Stable Mammalian Cell Lines for Regulated Expression of Proteins Using the Gateway(R) Recombination Cloning Technology and Flp-In T-REx(R) Lines. Methods Enzymol 2013;529:99-124.
72. Wu H, Mao C, Duenstl G, et al. Assay development of inducible human renal phosphate transporter Npt2A (SLC34A1) in Flp-In-Trex-HEK293 cells. Eur J Pharmacol 2013;721(1-3):332-40.
73. Wong ET, Kolman JL, Li YC, et al. Reproducible doxycycline-inducible transgene expression at specific loci generated by Cre-recombinase mediated cassette exchange. Nucleic Acids Res 2005;33:e147.
74. Verhoeyen E, Hauser H, Wirth D. Evaluation of retroviral vector design in defined chromosomal loci by Flp-mediated cassette replacement. Hum Gene Ther 2001;12:933-44.
75. Schucht R, Coroadinha AS, Zanta-Boussif MA, et al. A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors. Mol Ther 2006;14:285-92.
76. Sandhu U, Cebula M, Behme S, et al. Strict control of transgene expression in a mouse model for sensitive biological applications based on RMCE compatible ES cells. Nucleic Acids Res 2011;39:e1.
77. Turan S, Galla M, Ernst E, et al. Recombinase-mediated cassette exchange (RMCE): traditional concepts and current challenges. J Mol Biol 2011;407:193-221.
78. Gama-Norton L, Botezatu L, Herrmann S, et al. Lentivirus production is influenced by SV40 large T-antigen and chromosomal integration of the vector in HEK293 cells. Hum Gene Ther 2011;22:1269-79.
79. Strathdee D, Ibbotson H, Grant SG. Expression of transgenes targeted to the Gt(ROSA)26Sor locus is orientation dependent. PLoS One 2006;1:e4.
80. Nehlsen K, da Gama-Norton L, Schucht R, et al. Towards rational engineering of cells: Recombinant gene expression in defined chromosomal loci. BMC Proc 2011;5 Suppl 8:O6.
81. Nehlsen K, Schucht R, da Gama-Norton L, et al. Recombinant protein expression by targeting pre-selected chromosomal loci. BMC Biotechnology 2009;9:100.
82. Tchorz JS, Suply T, Ksiazek I, et al. A modified RMCE-compatible Rosa26 locus for the expression of transgenes from exogenous promoters. PLoS One 2012;7:e30011.
83. Chen CM, Krohn J, Bhattacharya S, et al. A comparison of exogenous promoter activity at the ROSA26 locus using a PhiiC31 integrase mediated cassette exchange approach in mouse ES cells. PLoS One 2011;6:e23376.
84. Schucht R, Lydford S, Andzinski L, et al. Rapid establishment of G-protein-coupled receptor-expressing cell lines by site-specific integration. J Biomol Screen 2011;16:323-31.
85. Carrondo M, Panet A, Wirth D, et al. Integrated strategy for the production of therapeutic retroviral vectors. Hum Gene Ther 2011;22:370-9.
86. Zhou H, Liu ZG, Sun ZW, et al. Generation of stable cell lines by site-specific integration of transgenes into engineered Chinese hamster ovary strains using an FLP-FRT system. J Biotechnol 2010;147:122-9.
87. Kaufman WL, Kocman I, Agrawal V, et al. Homogeneity and persistence of transgene expression by omitting antibiotic selection in cell line isolation. Nucleic Acids Res 2008;36:e111.
88. Kawabe Y, Makitsubo H, Kameyama Y et al. Repeated integration of antibody genes into a pre-selected chromosomal locus of CHO cells using an accumulative site-specific gene integration system. Cytotechnology 2012;64:267-79.
89. Crawford Y Zhou M, Hu Z, et al. Fast identification of reliable hosts for targeted cell line development from a limited-genome screening using combined phiC31 integrase and CRE-Lox technologies. Biotechnology Prog 2013;29(5):1307-15.
90. Kito M, Itami S, Fukano Y et al. Construction of engineered CHO strains for high-level production of recombinant proteins. Appl Microbiol Biotechnol 2002;60:442-8.
91. Huang Y, Li Y Wang YG, et al. An efficient and targeted gene integration system for high-level antibody expression. J Immunol Methods 2007;322(1-2):28-39.
92. Kim MS, Lee GM. Use of Flp-mediated cassette exchange in the development of a CHO cell line stably producing erythropoietin. J Microbiol Biotechnol 2008;18:1342-51.
93. Wilke S, Groebe L, Maffenbeier V, et al. Streamlining homogeneous glycoprotein production for biophysical and structural applications by targeted cell line development. PLoS One 2011;6:e27829.
94. Wiberg FC, Rasmussen SK, Frandsen TP, et al. Production of target-specific recombinant human polyclonal antibodies in mammalian cells. Biotechnol Bioeng 2006;94:396-405.
95. Coroadinha AS, Schucht R, Gama-Norton L, et al. The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange. J Biotechnol 2006;124:457-68.
96. Gama-Norton L, Herrmann S, Schucht R, et al. Retroviral vector performance in defined chromosomal Loci of modular packaging cell lines. Hum Gene Ther 2010;21:979-91.
97. Mao J, Barrow J, McMahon J, et al. An ES cell system for rapid, spatial and temporal analysis of gene function in vitro and in vivo. Nucleic Acids Res 2005;33:e155.
98. Ortiz-Urda S, Thyagarajan B, Keene DR, et al. Stable nonviral genetic correction of inherited human skin disease. Nat Med 2002;8:1166-70.
99. Olivares EC, Hollis RP, Chalberg TW, et al. Site-specific genomic integration produces therapeutic Factor IX levels in mice. Nat Biotechnol 2002;20:1124-8.
100. Held PK, Olivares EC, Aguilar CP, et al. In vivo correction of murine hereditary tyrosinemia type I by phiC31 integrase-mediated gene delivery. Mol Ther 2005;11:399-408.
101. Beard C, Hochedlinger K, Plath K, et al. Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis 2006;44:23-8.
102. Perez-Pinera P, Ousterout DG, Brown MT, et al. Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleases. Nucleic Acids Res 2012;40:3741-52.
103. Shmerling D, Danzer CP, Mao X, et al. Strong and ubiquitous expression of transgenes targeted into the beta-actin locus by Cre/lox cassette replacement. Genesis 2005;42:229-35.
104. Wei QX, Odell AF, van der Hoeven F, et al. Rapid derivation of genetically related mutants from embryonic cells harboring a recombinase-specific Trp53 platform. Cell Cycle 2011;10:1261-70.
105. Wallace HA, Marques-Kranc F, Richardson M, et al. Manipulating the mouse genome to engineer precise functional syntenic replacements with human sequence. Cell 2007;128:197-209.
106. Buchholz F, Angrand PO, Stewart AF. A simple assay to determine the functionality of Cre or FLP recombination targets in genomic manipulation constructs. Nucleic Acids Res 1996;24:3118-9.
107. Buchholz F, Angrand PO, Stewart AF. Improved properties of FLP recombinase evolved by cycling mutagenesis. Nat Biotechnol 1998;16:657-62.
108. Raymond CS, Soriano P. High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells. PLoS One 2007;2:e162.
109. Hirsch MR, d'Autreaux F, Dymecki SM, et al. A Phox2b::FLPo transgenic mouse line suitable for intersectional genetics. Genesis 2013;51:506-14.
110. Kranz A, Fu J, Duerschke K, et al. An improved Flp deleter mouse in C57Bl/6 based on Flpo recombinase. Genesis 2010;48:512-20.
111. Wu Y Wang C, Sun H, et al. High-efficient FLPo deleter mice in C57BL/6J background. PLoS One 2009;4:e8054.
112. Turan S, Galla M, Ernst E, et al. Recombinase-mediated cassette exchange (RMCE): traditional concepts and current challenges. J Mol Biol 2011;407:193-221.
113. Shimshek DR, Kim J, Hubner MR, et al. Codon-improved Cre recombinase (iCre) expression in the mouse. Genesis 2002;32:19-26.
114. Sauer B, McDermott J. DNA recombination with a heterospecific Cre homolog identified from comparison of the pac-c1 regions of P1-related phages. Nucleic Acids Res 2004;32:6086-95.
115. Minorikawa S, Nakayama M. Recombinase-mediated cassette exchange (RMCE) and BAC engineering via VCre/VloxP and SCre/SloxP systems. Biotechniques 2011;50:235-46.
116. Suzuki E, Nakayama M. VCre/VloxP and SCre/SloxP: new site-specific recombination systems for genome engineering. Nucleic Acids Res 2011;39:e49.
117. Karimova M, Abi-Ghanem J, Berger N, et al. Vika/vox, a novel efficient and specific Cre/loxP-like site-specific recombination system. Nucleic Acids Res 2013;41:e37.
118. Preuss E, Treschow A, Newrzela S, et al. TK.007: A novel, codon-optimized HSVtk(A168H) mutant for suicide gene therapy. Hum Gene Ther 2010;21:929-41.
119. Loonstra A, Vooijs M, Beverloo HB, et al. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci USA 2001;98:9209-14.
120. Baba Y Nakano M, Yamada Y et al. Practical range of effective dose for Cre recombinase-expressing recombinant adenovirus without cell toxicity in mammalian cells. Microbiol Immunol 2005;49:559-70.
121. Ehrhardt A, Engler JA, Xu H, et al. Molecular analysis of chromosomal rearrangements in mammalian cells after phiC31-mediated integration. Hum Gene Ther 2006;17:1077-94.
122. Thyagarajan B, Guimaraes MJ, Groth AC, et al. Mammalian genomes contain active recombinase recognition sites. Gene 2000;244:47-54.
123. Semprini S, Troup TJ, Kotelevtseva N, et al. Cryptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of BAC/PAC recombineering techniques. Nucleic Acids Res 2007;35:1402-10.
124. Thomas KR, Capecchi MR. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987;51:503-12.
125. Doetschman T, Gregg RG, Maeda N, et al. Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 1987;330:576-8.
126. Capecchi MR. Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat Rev Genet 2005;6:507-12.
127. Babinet C, Cohen-Tannoudji M. Genome engineering via homologous recombination in mouse embryonic stem (ES) cells: an amazingly versatile tool for the study of mammalian biology. An Acad Bras de Cienc 2001;73:365-83.
128. Cervantes RB, Stringer JR, Shao C, et al. Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc Natl Acad Sci USA 2002;99:35 86-90.
129. Hasty P, Rivera-Perez J, Bradley A. The length of homology required for gene targeting in embryonic stem cells. Mol Cell Biol 1991;11:5586-91.
130. Templeton NS, Roberts DD, Safer B. Efficient gene targeting in mouse embryonic stem cells. Gene Ther 1997;4:700-9.
131. Sedivy JM, Sharp PA. Positive genetic selection for gene disruption in mammalian cells by homologous recombination. Proc Natl Acad Sci USA 1989;86:227-31.
132. te Riele H, Maandag ER, Berns A. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. Proc Natl Acad Sci USA 1992;89:5128-32.
133. Lu ZH, Books JT, Kaufman RM, et al. Long targeting arms do not increase the efficiency of homologous recombination in the beta-globin locus of murine embryonic stem cells. Blood 2003;102:1531-3.
134. Porteus M. Using homologous recombination to manipulate the genome of human somatic cells. Biotechnol Gent Eng Rev 2007;24:195-212.
135. Tichy ED, Pillai R, Deng L, et al. Mouse embryonic stem cells, but not somatic cells, predominantly use homologous recombination to repair double-strand DNA breaks. Stem Cells Dev 2010;19:1699-711.
136. Smithies O, Gregg RG, Boggs SS, et al. Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature 1985;317:230-4.
137. Brown JP, Wei W, Sedivy JM. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997;277:831-4.
138. Bunz F, Dutriaux A, Lengauer C, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998;282:1497-501.
139. Buerstedde JM, Takeda S. Increased ratio of targeted to random integration after transfection of chicken B cell lines. Cell 1991;67:179-88.
140. Storck S, Thiry M, Bouvet P. Conditional knockout of nucleolin in DT40 cells reveals the functional redundancy of its RNA-binding domains. Biol Cell 2009;101:153-67.
141. Lee S, Liu X, Takeda S, et al. Genotoxic potentials and related mechanisms of bisphenol A and other bisphenol compounds: a comparison study employing chicken DT40 cells. Chemosphere 2013;93:434-40.
142. Qing Y Yamazoe M, Hirota K, et al. The epistatic relationship between BRCA2 and the other RAD51 mediators in homologous recombination. PLoS genetics 2011;7:e1002148.
143. Thomas BJ, Rothstein R. Elevated recombination rates in transcriptionally active DNA. Cell 1989;56:619-30.
144. Russell DW, Hirata RK. Human gene targeting by viral vectors. Nat Genet 1998;18:325-30.
145. Chamberlain JR, Deyle DR, Schwarze U, et al. Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta. Mol Ther 2008;16:187-93.
146. Miller DG, Wang PR, Petek LM, et al. Gene targeting in vivo by adeno-associated virus vectors. Nat Biotechnol 2006;24:1022-6.
147. Chamberlain JR, Schwarze U, Wang PR, et al. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 2004;303:1198-201.
148. Rouet P, Smih F, Jasin M. Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease. Mol Cell Biol 1994;14:8096-106.
149. Choulika A, Perrin A, Dujon B, et al. Induction of homologous recombination in mammalian chromosomes by using the I-SceI system of Saccharomyces cerevisiae. Mol Cell Biol 1995;15:1968-73.
150. Elliott B, Richardson C, Winderbaum J, et al. Gene conversion tracts from double-strand break repair in mammalian cells. Mol Cell Biol 1998;18:93-101.
151. Cohen-Tannoudji M, Robine S, Choulika A, et al. I-SceI-induced gene replacement at a natural locus in embryonic stem cells. Mol Cell Biol 1998;18:1444-8.
152. Donoho G, Jasin M, Berg P. Analysis of gene targeting and intrachromosomal homologous recombination stimulated by genomic double-strand breaks in mouse embryonic stem cells. Mol Cell Biol 1998;18:4070-8.
153. Porteus MH, Baltimore D. Chimeric nucleases stimulate gene targeting in human cells. Science 2003;300:763.
154. Orlando SJ, Santiago Y DeKelver RC, et al. Zinc-finger nuclease-driven targeted integration into mammalian genomes using donors with limited chromosomal homology. Nucleic Acids Res 2010;38:e152.
155. Burt A, Koufopanou V. Homing endonuclease genes: the rise and fall and rise again of a selfish element. Curr Opin Genet Dev 2004;14:609-15.
156. Hartlerode A, Odate S, Shim I, et al. Cell cycle-dependent induction of homologous recombination by a tightly regulated I-SceI fusion protein. PLoS One 2011;6:e16501.
157. Bellaiche Y Mogila V, Perrimon N. I-SceI endonuclease, a new tool for studying DNA doublestrand break repair mechanisms in Drosophila. Genetics 1999;152:1037-44.
158. Szczepek M, Brondani V, Buchel J, et al. Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nat Biotechnol 2007;25:786-93.
159. Fenina M, Simon-Chazottes D, Vandormael-Pournin S, et al. I-SceI-mediated double-strand break does not increase the frequency of homologous recombination at the Dct locus in mouse embryonic stem cells. PLoS One 2012;7:e39895.
160. Valton J, Daboussi F, Leduc S, et al. 5’-Cytosine-phosphoguanine (CpG) methylation impacts the activity of natural and engineered meganucleases. J Biol Chem 2012;287:30139-50.
161. Gouble A, Smith J, Bruneau S, et al. Efficient in toto targeted recombination in mouse liver by meganuclease-induced double-strand break. J Gene Med 2006;8:616-22.
162. Seligman LM, Chisholm KM, Chevalier BS, et al. Mutations altering the cleavage specificity of a homing endonuclease. Nucleic Acids Res 2002;30:3870-9.
163. Rosen LE, Morrison HA, Masri S, et al. Homing endonuclease I-CreI derivatives with novel DNA target specificities. Nucleic Acids Res 2006;34:4791-800.
164. Segal DJ, Meckler JF. Genome engineering at the dawn of the golden age. Annu Rev Genomics Hum Genet 2013;14:135-58.
165. Choo Y, Klug A. Selection of DNA binding sites for zinc fingers using rationally randomized DNA reveals coded interactions. Proc Natl Acad Sci USA 1994;91:11168-72.
166. Rebar EJ, Pabo CO. Zinc finger phage: affinity selection of fingers with new DNA-binding specificities. Science 1994;263:671-3.
167. Davis D, Stokoe D. Zinc finger nucleases as tools to understand and treat human diseases. BMC Medicine 2010;8:42.
168. Wilson KA, McEwen AE, Pruett-Miller SM, et al. Expanding the Repertoire of Target Sites for Zinc Finger Nuclease-mediated Genome Modification. Mol Ther Nucleic Acids 2013;2:e88.
169. Urnov FD, Rebar EJ, Holmes MC, et al. Genome editing with engineered zinc finger nucleases. Nat Rev Genet 2010;11:636-46.
170. Klug A. The discovery of zinc fingers and their applications in gene regulation and genome manipulation. Annu Rev Biochem 2010;79:213-31.
171. Wirt SE, Porteus MH. Development of nuclease-mediated site-specific genome modification. Curr Opin Immunol 2012;24:609-16.
172. Gabriel R, Lombardo A, Arens A, et al. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol 2011;29:816-23.
173. Pattanayak V, Ramirez CL, Joung JK, et al. Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat Meth 2011;8:765-70.
174. Gupta A, Christensen RG, Rayla AL, et al. An optimized two-finger archive for ZFN-mediated gene targeting. Nat Meth 2012;9:588-90.
175. Kim JS, Lee HJ, Carroll D. Genome editing with modularly assembled zinc-finger nucleases. Nat Meth 2010;7:91.
176. Miller JC, Holmes MC, Wang J, et al. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol 2007;25:778-85.
177. Doyon Y Vo TD, Mendel MC, et al. Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat Meth 2011;8:74-9.
178. Guo J, Gaj T, Barbas CF, 3rd. Directed evolution of an enhanced and highly efficient FokI cleavage domain for zinc finger nucleases. J Mol Biol 2010;400:96-107.
179. Gaj T, Guo J, Kato Y et al. Targeted gene knockout by direct delivery of zinc-finger nuclease proteins. Nat Meth 2012;9:805-7.
180. Pruett-Miller SM, Reading DW, Porter SN, et al. Attenuation of zinc finger nuclease toxicity by small-molecule regulation of protein levels. PLoS Genet 2009;5:e1000376.
181. McConnell Smith A, Takeuchi R, Pellenz S, et al. Generation of a nicking enzyme that stimulates site-specific gene conversion from the I-AniI LAGLIDADG homing endonuclease. Proc Natl Acad Sci USA 2009;106:5099-104.
182. Kim E, Kim S, Kim DH, et al. Precision genome engineering with programmable DNA-nicking enzymes. Genome Res 2012;22:1327-33.
183. Wang J, Friedman G, Doyon Y et al. Targeted gene addition to a predetermined site in the human genome using a ZFN-based nicking enzyme. Genome Res 2012;22:1316-26.
184. Ramirez CL, Certo MT, Mussolino C, et al. Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects. Nucleic Acids Res 2012;40:5560-8.
185. Boch J, Scholze H, Schornack S, et al. Breaking the code of DNA binding specificity of TAL-type III effectors. Science 2009;326:1509-12.
186. Moscou MJ, Bogdanove AJ. A simple cipher governs DNA recognition by TAL effectors. Science 2009;326:1501.
187. Deng D, Yan C, Pan X, et al. Structural basis for sequence-specific recognition of DNA by TAL effectors. Science 2012;335:720-3.
188. Doyle EL, Booher NJ, Standage DS, et al. TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction. Nucleic Acids Res 2012;40:W117-22.
189. Cermak T, Doyle EL, Christian M, et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 2011;39:e82.
190. Moore FE, Reyon D, Sander JD, et al. Improved somatic mutagenesis in zebrafish using transcription activator-like effector nucleases (TALENs). PLoS One 2012;7:e37877.
191. Sun N, Zhao H. Transcription activator-like effector nucleases (TALENs): a highly efficient and versatile tool for genome editing. Biotechnol Bioeng 2013;110:1811-21.
192. Schmid-Burgk JL, Schmidt T, Kaiser V, et al. A ligation-independent cloning technique for high-throughput assembly of transcription activator-like effector genes. Nat Biotechnol 2013;31:76-81.
193. Reyon D, Maeder ML, Khayter C, et al. Engineering customized TALE nucleases (TALENs) and TALE transcription factors by fast ligation-based automatable solid-phase high-throughput (FLASH) assembly. Curr Protoc Mol Bio 2013;Chapter 12:Unit 12.16.
194. Briggs AW, Rios X, Chari R, et al. Iterative capped assembly: rapid and scalable synthesis of repeat-module DNA such as TAL effectors from individual monomers. Nucleic Acids Res 2012;40:e117.
195. Sanjana NE, Cong L, Zhou Y et al. A transcription activator-like effector toolbox for genome engineering. Nat Protoc 2012;7:171-92.
196. Morbitzer R, Elsaesser J, Hausner J, et al. Assembly of custom TALE-type DNA binding domains by modular cloning. Nucleic Acids Res 2011;39:5790-9.
197. Hockemeyer D, Soldner F, Beard C, et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol 2009;27:851-7.
198. Mahfouz MM, Li L, Shamimuzzaman M, et al. De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks. Proc Natl Acad Sci USA 2011;108:2623-8.
199. Li Y Moore R, Guinn M, et al. Transcription activator-like effector hybrids for conditional control and rewiring of chromosomal transgene expression. Sci Rep 2012;2:897.
200. Holkers M, Maggio I, Liu J, et al. Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res 2013;41:e63.
201. Jinek M, Chylinski K, Fonfara I, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012;337:816-21.
202. Horvath P, Barrangou R. CRISPR/Cas, the immune system of bacteria and archaea. Science 2010;327:167-70.
203. Ran FA, Hsu PD, Wright J, et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc 2013;8:2281-308.
204. Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013;339:819-23.
205. Yang H, Wang H, Shivalila CS, et al. One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome Engineering. Cell 2013;154:1370-9.
206. Wang H, Yang H, Shivalila CS, et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 2013;153:910-8.
207. Cho SW, Kim S, Kim JM, et al. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 2013;31:230-2.
208. Mali P, Yang L, Esvelt KM, et al. RNA-guided human genome engineering via Cas9. Science 2013;339:823-6.
209. Hwang WY, Fu Y Reyon D, et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 2013;31:227-9.
210. DiCarlo JE, Norville JE, Mali P, et al. Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res 2013;41:4336-43.
211. Jiang W, Bikard D, Cox D, et al. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol 2013;31:233-9.
212. Fu Y, Foden JA, Khayter C, et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 2013;31:822-6.
213. Cradick TJ, Fine EJ, Antico CJ, et al. CRISPR/Cas9 systems targeting beta-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res 2013;41:9584-92.
214. Ran FA, Hsu PD, Lin CY et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 2013;154:1380-9.
215. Soldner F, Laganiere J, Cheng AW, et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 2011;146:318-31.
216. Yusa K, Rashid ST, Strick-Marchand H, et al. Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells. Nature 2011;478:391-4.
217. Zou J, Mali P, Huang X, et al. Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. Blood 2011;118:4599-608.
218. Santiago Y, Chan E, Liu PQ, et al. Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci USA 2008;105:5809-14.
219. Malphettes L, Freyvert Y, Chang J, et al. Highly efficient deletion of FUT8 in CHO cell lines using zinc-finger nucleases yields cells that produce completely nonfucosylated antibodies. Biotechnol Bioeng 2010;106:774-83.
220. Sealover NR, Davis AM, Brooks JK, et al. Engineering Chinese hamster ovary (CHO) cells for producing recombinant proteins with simple glycoforms by zinc-finger nuclease (ZFN)-mediated gene knockout of mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglu-cosaminyltransferase (Mgat1). J Biotechnol 2013;167:24-32.
221. Liu PQ, Chan EM, Cost GJ, et al. Generation of a triple-gene knockout mammalian cell line using engineered zinc-finger nucleases. Biotechnol Bioeng 2010;106:97-105.
222. Cost GJ, Freyvert Y Vafiadis A, et al. BAK and BAX deletion using zinc-finger nucleases yields apoptosis-resistant CHO cells. Biotechnol Bioeng 2010;105:330-40.
223. Paques F, Duchateau P. Meganucleases and DNA double-strand break-induced recombination: perspectives for gene therapy. Curr Gene Rher 2007;7:49-66.
224. Papapetrou EP, Lee G, Malani N, et al. Genomic safe harbors permit high beta-globin transgene expression in thalassemia induced pluripotent stem cells. Nat Biotechnol 2011;29:73-8.
225. Sadelain M, Papapetrou EP, Bushman FD. Safe harbours for the integration of new DNA in the human genome. Nat Rev Cancer 2012;12:51-8.
226. Nunez E, Fu XD, Rosenfeld MG. Nuclear organization in the 3D space of the nucleus - cause or consequence? Curr Opin Genet Dev 2009;19:424-36.
227. Nehlsen K, da Gama-Norton L, Schucht R, et al. Towards rational engineering of cells: Recombinant gene expression in defined chromosomal loci. BMC Proc 2011;5 Suppl 8:O6.
228. Thomason L, Court DL, Bubunenko M, et al. Recombineering: genetic engineering in bacteria using homologous recombination. Curr Protoc Mol Biol 2007;Chapter 1:Unit 1 16.
229. Copeland NG, Jenkins NA, Court DL. Recombineering: a powerful new tool for mouse functional genomics. Nat Rev Genet 2001;2:769-79.
230. Narayanan K, Chen Q. Bacterial artificial chromosome mutagenesis using recombineering. J Biomed Biotechnol 2011;2011:9712-96.
231. Muyrers JP, Zhang Y Benes V, et al. Point mutation of bacterial artificial chromosomes by ET recombination. EMBO Rep 2000;1:239-43.
232. Warming S, Costantino N, Court DL, et al. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 2005;33:e36.
233. Zhang Y Muyrers JP, Rientjes J, et al. Phage annealing proteins promote oligonucleotide-directed mutagenesis in Escherichia coli and mouse ES cells. BMC Mol Biol 2003;4:1.
234. Bird AW, Erler A, Fu J, et al. High-efficiency counterselection recombineering for site-directed mutagenesis in bacterial artificial chromosomes. Nat Meth 2012;9:103-9.
235. Li MA, Turner DJ, Ning Z, et al. Mobilization of giant piggyBac transposons in the mouse genome. Nucleic Acids Res 2011;39:e148.
236. Rostovskaya M, Fu J, Obst M, et al. Transposon-mediated BAC transgenesis in human ES cells. Nucleic Acids Res 2012;40:e150.
237. Pulverer JE, Rand U, Lienenklaus S, et al. Temporal and spatial resolution of type I and III interferon responses in vivo. J Virol 2010;84:8626-38.
238. Poser I, Sarov M, Hutchins JR, et al. BAC TransgeneOmics: a high-throughput method for exploration of protein function in mammals. Nat Meth 2008;5:409-15.
239. Blaas L, Musteanu M, Grabner B, et al. The Use of Bacterial Artificial Chromosomes for Recombinant Protein Production in Mammalian Cell Lines Recombinant Gene Expression. In: Lorence A (ed): Springer New York; 2012:581-93.
240. Blaas L, Musteanu M, Eferl R, et al. Bacterial artificial chromosomes improve recombinant protein production in mammalian cells. BMC Biotechnol 2009;9:3.
241. Bian Q, Belmont AS. BAC TG-EMBED: one-step method for high-level, copy-number-dependent, position-independent transgene expression. Nucleic Acids Res 2010;38:e127.
242. Kazuki Y Oshimura M. Human artificial chromosomes for gene delivery and the development of animal models. Mol Ther 2011;19:1591-601.
243. Kennard ML. Engineered mammalian chromosomes in cellular protein production: future prospects. Meth Mol Biol 2011;738:217-38.
244. Kouprina N, Earnshaw WC, Masumoto H, et al. A new generation of human artificial chromosomes for functional genomics and gene therapy. Cell Mol Life Sci 2013;70:1135-48.
245. Lufino MM, Edser PA, Wade-Martins R. Advances in high-capacity extrachromosomal vector technology: episomal maintenance, vector delivery, and transgene expression. Mol Ther 2008;16:1525-38.
246. Mizuguchi H, Hosono T, Hayakawa T. Long-term replication of Epstein-Barr virus-derived episomal vectors in the rodent cells. FEBS Lett 2000;472:173-8.
247. Ito S, Gotoh E, Ozawa S, et al. Epstein-Barr virus nuclear antigen-1 is highly colocalized with interphase chromatin and its newly replicated regions in particular. J Gen Virol 2002;83:2377-83.
248. Hagedorn C, Wong SP, Harbottle R, Lipps HJ. Scaffold/matrix attached region-based nonviral episomal vectors. Hum Gene Ther 2011;22:915-23.
249. Baiker A, Maercker C, Piechaczek C, et al. Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix. Nat Cell Biol 2000;2:182-4.
250. Stehle IM, Postberg J, Rupprecht S, et al. Establishment and mitotic stability of an extra-chromosomal mammalian replicon. BMC Cell Biol 2007;8:33.
251. Stehle IM, Scinteie MF, Baiker A, et al. Exploiting a minimal system to study the epigenetic control of DNA replication: the interplay between transcription and replication. Chromosome Res 2003;11:413-21.
252. Jenke AC, Stehle IM, Herrmann F, et al. Nuclear scaffold/matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome. Proc Natl Acad Sci USA 2004;101:11322-7.
253. Piechaczek C, Fetzer C, Baiker A, et al. A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. Nucleic Acids Res 1999;27:426-8.
254. Papapetrou EP, Ziros PG, Micheva ID, et al. Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element. Gene Ther 2006;13:40-51.
255. Lufino MM, Poppleston AR, Cowley SA, et al. Episomal transgene expression in pluripotent stem cells. Methods Mol Biol 2011;767:369-87.
256. Manzini SA, Vargiolu IM, Stehle ML, et al. Genetically modified pigs produced with a nonviral episomal vector. Proc Natl Acad Sci USA 2006;103(47):17672-7.
257. Argyros O, Wong SP, Harbottle RP. Non-viral episomal modification of cells using S/MAR elements. Expert Opin Biol Ther 2011;11:1177-91.
258. Hacker DL, Kiseljak D, Rajendra Y et al. Polyethyleneimine-based transient gene expression processes for suspension-adapted HEK-293E and CHO-DG44 cells. Protein Expr Purif 2013;92:67-76.